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Abstract
We have developed a unified, versatile vector set for expression of recombinant proteins, fit
for use in any bacterial, yeast, insect or mammalian cell host. The advantage of this system
is its versatility at the vector level, achieved by the introduction of a novel expression cas-
sette. This cassette contains a unified multi-cloning site, affinity tags, protease cleavable
linkers, an optional secretion signal, and common restriction endonuclease sites at key posi-
tions. This way, genes of interest and all elements of the cassette can be switched freely
among the vectors, using restriction digestion and ligation without the need of polymerase
chain reaction (PCR). This vector set allows rapid protein expression screening of various
hosts and affinity tags. The reason behind this approach was that it is difficult to predict
which expression host and which affinity tag will lead to functional expression. The new sys-
tem is based on four optimized and frequently used expression systems (Escherichia coli
pET, the yeast Pichia pastoris, pVL and pIEx for Spodoptera frugiperda insect cells and
pLEXm based mammalian systems), which were modified as described above. The result-
ing vector set was named pONE series. We have successfully applied the pONE vector set
for expression of the following human proteins: the tumour suppressor RASSF1A and the
protein kinases Aurora A and LIMK1. Finally, we used it to express the large multidomain
protein, Rho-associated protein kinase 2 (ROCK2, 164 kDa) and demonstrated that the
yeast Pichia pastoris reproducibly expresses the large ROCK2 kinase with identical activity
to the insect cell produced counterpart. To our knowledge this is among the largest proteins
ever expressed in yeast. This demonstrates that the cost-effective yeast system can match
and replace the industry-standard insect cell expression system even for large and complex
mammalian proteins. These experiments demonstrate the applicability of our pONE vector
set.
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Introduction
Finding the optimal host for the expression of proteins for research purposes often involves
expensive and time-consuming testing in multiple expression systems. Since different vectors
were developed independently [1–3], they are usually not compatible, holding a different set of
restriction sites. This means that in many cases the gene of interest needs to be re-cloned into
each vector to be tried, even if the gene itself is unchanged. The expression screening process
can be sped up by the use of vectors tailored/designed specifically for quick exchange of genes
of interest. One such approach is the pAUL vector system developed for Arabidopsis thaliana
[4]. There is also the pCri System with vectors for E. coli, B. subtilis and P. pastoris [5]. Other
systems are aimed to handle different problems (e.g. gene-delivery [6], recombinant antibody
expression [7] or metabolic engineering in yeast [8].
In this paper we describe a new set of expression vectors, unified for a wide variety of host
cells, such as E. coli (bacterium), P. pastoris (yeast), S. frugiperda (insect), and mammalian cells
(human embryonic kidney [HEK] and chinese hamster ovary [CHO]). These vectors allow
rapid swapping of genetic elements among themselves: they carry a unified multiple cloning
site (Fig 1), enabling quick transfer of the target gene from one vector to another by simple
excision and ligation. This arrangement also allows modular exchange of secretion signals,
affinity tags and protease cleavable linkers among them. Here we describe the development
process, involving the reduction or elimination of several restriction sites from the backbone
of the vectors. In addition, we demonstrate the functionality of the modified vector set by
expressing the maltose binding protein (MBP), often used for affinity labelling, as a reporter
protein.
Finally, we show the usefulness of the vector set through its application to a practical prob-
lem: expression screening of a large human protein kinase, ROCK2, a large multidomain and
multifunctional protein. Disturbances in ROCK2 function are associated with neurodegenera-
tive diseases [9]. ROCK2 has been successfully expressed in the past in insect cell cultures [10].
Our expression screening reveals that ROCK2 kinase expressed in P. pastoris is functionally
equivalent to that produced using insect cells. We also managed to purify the protein. To our
knowledge, ROCK2 may well be the largest (a dimer of two 164 kDa chains) protein success-
fully expressed and purified from yeast so far. For comparison only the expression of the
Fig 1. Features of the expression casette in the pONE vector set. The expression cassette begins with an N-terminal
secretion signal, followed by a sequence of MBP affinity tag, a protease cleavable linker, the multiple cloning site, and
finally a C-terminal His-tag. All of these elements are exchangeable among the vectors, provided the restriction sites
are compatible. Many, but not all, restriction sites are compatible among the vectors. There is at least one appropriate
restriction enzyme combination for each possible pair of vectors. Minimal requirements that make a vector “pONE”
compatible: NcoI and flanking NotI and XhoI sites. At least one of AgeI/KpnI/BamHI sites at the affinity tag/cleavage
tag boundary. One of the NheI/AvrII pair. One of the EcoRI/MfeI pair. The pairs generate compatible overhangs,
therefore they may be ligated together. (A) Schematic of the multiple cloning site. (B) Sequence details of the
intracellular MBP-TEV variant of vectors. (C) Sequence details of the secreted MBP-WELQ variant of vectors.
https://doi.org/10.1371/journal.pone.0227110.g001
A unified and modular vector set for recombinant protein expression
PLOS ONE | https://doi.org/10.1371/journal.pone.0227110 December 30, 2019 2 / 17
complex α3β1 isoform of Na, K ATPase (chain sizes of 110 and 35 kDa, respectively) may be
mentioned [11]. The successful production of ROCK2 is an important achievement, since
yeast expression systems [2] are cost-effective and scalable. Furthermore, we have demon-
strated successful expression of other important human kinases, namely LIM domain kinase 1
(LIMK1) [12] and Aurora kinase A [13] as well as a tumour suppressor protein, Ras associa-
tion domain-containing protein 1A (RASSF1A) (e.g. [14, 15] by the aid of the elaborated
pONE vector set.
Materials and methods
Modification of expression plasmids, construction of pONE vectors
Modification and assembly of recombinant expression plasmids involved standard laboratory
practices: polymerase chain reaction, PCR based mutagenesis, restriction digestion and liga-
tion. Relevant protocols are available [16–18]. To unify the multiple cloning sites of the vec-
tors, several restriction sites were removed from the vector backbones using mutagenesis or by
a procedure involving restriction digestion of the vector, followed by overhang filling and
finally, religation of the vector via the newly formed blunt ends. Sequences encoding for cer-
tain affinity tags, secretion signals and protease cleavage sites were also cloned into the vectors,
yielding the “pONE” series of vectors. The signal sequence and tags are also separated by well-
placed restriction sites for easy exchange between different signals and tags (Fig 1). Despite
our efforts, not all restriction sites may work in all vectors, however, there is at least one set of
restriction sites that will be unique. The usable (unique) restriction sites are marked in Fig 2
for each of the vectors. For these vectors (Table 1) we propose an easy-to-remember nomen-
clature, using the following logic: all names begin with pONE-, followed by a number with its
first digit denoting the host (1: bacteria, 2: yeast, 3: insect and 4: mammalian)–the second digit
is for distinguishing between the individual vectors. Vector names are terminated by a letter
marking the antibiotic resistance in the vector (A: ampicillin, K: kanamycin). The resulting
vector sequences are available in the supplemental data (S1 Sequences).
Testing the pONE vectors in protein expression experiments
Protein expression was carried out using standard procedures described in the relevant manu-
facturer/developer supplied manuals for the Escherichia coli pET system [20], transient expres-
sion system of insect cells [21], baculovirus-insect cell system [22] and the Pichia classic
system [23]. The mammalian transient expression system was based on the pLEXm vector
established by Cambridge researchers [1].
To examine protein expression levels among the different vectors, MBP (Maltose Binding
Protein) was expressed in itself, and protein yields were compared for each vector using West-
ern blot and densitometry. In addition, to test the vectors in a real-life project, the expression
levels of the complex full-length human ROCK2 kinase were also compared in the vectors
pONE-10K, -25A, -30A. The genes coding for the proteins were synthetized by Thermo Fisher
Scientific GeneArt using the codon preference of insect cells. The sequences are provided in S1
Sequences. Other proteins were also expressed successfully using pONE vectors: pONE-10K
proved efficient for expression and purification of Aurora kinase A and various truncated
forms of Ras association domain-containing protein 1A (RASSF1A), as well as galectins 13
and 14. LIM domain kinase 1 (LIMK1) was expressed using pONE-30A.
Expression trials in Escherichia coli. For protein expression in bacteria, E. coli BL21
(DE3) cells were transformed with the appropriate plasmids and plated on antibiotic-contain-
ing Luria-Bertani broth (LB; plus 50 μg/mL kanamycin or 100 μg/mL ampicillin). A selected
colony was inoculated in 20 mL LB medium and incubated overnight at 37˚C, 220 rpm in the
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presence of an antibiotic. Next day, 1 mL or 10 mL of the starter culture was used to inoculate
100 mL or 1 L of LB broth respectively and cells were grown at 37˚C, 220 rpm in the presence
of an antibiotic. Protein expression was induced by adding 1 mM IPTG to the cell cultures,
upon reaching an OD 600 density of ~0.8–0.9. Before induction, cultures were equilibrated to
induction temperature 30˚C for 0.5 hours. Protein expression was continued for 4 hours at
30˚C, 220 rpm.
Expression trials in Pichia pastoris. For expression in P. pastoris, recombinant protein
containing vectors were linearized using PmeI or AvrII restriction enzyme–depending on the
vector–and transformed via electroporation. Cleaved vector DNA targets the vector for inte-
gration into the yeast genome at the cleavage region. Without cleavage transformation effi-
ciency is low and may result in non-expressing clones. PmeI site is present in the vectors with
AOX1 promoter, while AvrII is present in the GAP promoter. It should be noted that AvrII is
not unique, however the other AvrII site is eliminated in most cloning strategies. If not, the
unique BglII site may be used, albeit this results in lower transformation efficiency. Cells were
plated on Minimal Dextrose (MD) plates (for vectors with HIS4 metabolic marker) and incu-
bated for 3 days at 30˚C. Freshly grown colonies from the plates were picked and grown in 20
mL or 3×100 mL YPD medium at 30˚C overnight at 280 rpm. The pre-inoculum was used to
inoculate 200 mL or 3×1 L Buffered Media with Glycerol (BMGY) medium and were grown
for 8 hours at 30˚C at 280 rpm in Erlenmeyer flasks. The flasks were not filled with more
media than 25% of nominal volume.
Expression trials in Spodoptera frugiperda. For the pVL based vectors pONE-30A and
-31A, Sf9 insect cells were co-transfected with expression plasmid and linearized baculovirus
DNA (Oxford Expression Technologies) in a 6-well plate. Baculovirus was amplified in two
further rounds (p1 and p2) as a monolayer culture to produce a virus stock ready for infection
of the expression cells. Sf9 insect cells at 2×106 cell/mL density were infected with recombinant
baculovirus to produce the protein of interest in 2 mL or 500 mL volume in Insect-Xpress
medium (Lonza). The infected cells were incubated for 3 days at 27˚C with constant shaking at
110 rpm.
Fig 2. Maps of the pONE vectors. Promoters (green) and the MBP gene (red) in each vector are represented by arrows showing the direction of transcription and
translation. Other important elements, depicted as rectangles are: 6X histidine tag (blue), resistance markers (orange) and replication origins (black). Secretion vectors
also have genes encoding secretion signals (brown) in fusion with MBP. Important, unique restriction sites of the expression cassette are also marked. (A) The only E.
coli vector of the set, pONE-10K carries the lacI and lacO elements of the lac operon (yellow). (B) Pichia pastoris vectors: pONE-23A (intracellular) and pONE-24A
(secretion) have the AOX1 promoter, while pONE-25A (intracellular) utilizes the GAP promoter. (C) Insect cell vectors: pONE-30A (intracellular) and pONE-31A
(secretion) are based on the baculovirus expression system, while pONE-32A (intracellular) and pONE-33A (secretion) can be used for transient transfection. (D)
Mammalian vectors, fit for transient transfection: pONE-40A (intracellular) and pONE-41A (secretion). Vector maps were produced using BioEdit [19].
https://doi.org/10.1371/journal.pone.0227110.g002
Table 1. The list of unified vectors of the pONE series.
Vector name Host cell Parental vector Final vector composition Type of vector Resistance marker Vector replication
pONE-10K E. coli pET-24d pET-MBP-TEV-His6 intracellular Kanamycin replicative
pONE-23A P. pastoris pPIC9K pPIC-MBP-TEV-His6 intracellular Ampicillin/none (metabolic selection in yeast) integrative
pONE-24A pPIC-sec-MBP-WELQut-His6 secretion
pONE-25A pPIC-GAP-MBP-TEV-His6 intracellular
pONE-30A S. frugiperda pVL1393 pVL-MBP-TEV-His6 intracellular Ampicillin replicative (virus)
pONE-31A pVL-sec-MBP-WELQut-His6 secretion
pONE-32A pIEx-1 pIEx-MBP-TEV-His6 intracellular transient
pONE-33A pIEx-sec-MBP-WELQut-His6 secretion
pONE-40A H. sapiens pLEXm pLEX-MBP-TEV-His6 intracellular Ampicillin transient
pONE-41A pLEX-sec-MBP-WELQut-His6 secretion
https://doi.org/10.1371/journal.pone.0227110.t001
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For transient transfection of Sf9 cells, pIEx based vectors pONE-32A and -33A were mixed
with Insect GeneJuice transfection reagent (Sigma-Aldrich) and added to cell cultures of
2×106 cell/mL density, as described in the Insect GeneJuice datasheet [24]. Transfected cells
were incubated for 72 hours at 27˚C, before further processing.
Expression trials in the human cell line HEK293. HEK293 mammalian cells were trans-
fected with the mixture of branched polyethylene-imine (No. 408727, Sigma-Aldrich) and
pONE-40A (or pONE-41A) constructs (ratio 3:1) at 5×105 cell/mL density in 2 mL Dulbecco’s
Modified Eagle’s Medium containing 10% FBS (Fetal Bovine Serum) and penicillin-streptomy-
cin antibiotic. Transfected cells were incubated for 72 hours at 37˚C in the presence of 5% car-
bon-dioxide. After incubation, cells were separated from the medium for further analysis.
Purification of the recombinant proteins. After expression, cells were separated from
the expression medium by centrifugation (10 min, 16000 g for E. coli, 4000 g for other hosts).
Proteins of interest were localised in different fractions depending on the expression method.
Proteins without a secretion signal accumulated inside the cytoplasm and had to be extracted
from the cells: The cells were resuspended in a buffer (25 mM HEPES, 500 mM NaCl, 10 mM
β-mercaptoethanol, 1 mM PMSF, pH 7.4). Then, cells were lysed via ultrasonic homogeniza-
tion. Cellular debris was pelleted using centrifugation (45 min, 44000 g), and the protein of
interest purified from the cellular supernatant.
Proteins expressed in fusion with a secretion signal appeared in the expression medium
and could be purified directly from it.
Before purification, cellular extract or the expression medium containing the protein of
interest was filtered through a syringe filter with a pore size of 0.2 μm. All proteins were puri-
fied using amylose affinity chromatography. Proteins of interest were eluted by 10 mM malt-
ose, and peak fractions were collected. Aurora A protein was subjected to Ni affinity
chromatography using 300 mM imidazole as eluent. Both Aurora A and RASSF1A were fur-
ther purified by size exclusion chromatography on a column loaded with preparative grade
Superose 12 resin.
Determination of protein expression yields. After purification, protein concentrations
were determined by UV spectrophotometry using molar extinction coefficients calculated on
the basis of a previously published method [25]. Total protein yields for each batch were calcu-
lated from the concentration data and the molar weights of the recombinant proteins. Yields
were normalized for wet cellular mass measured during each expression.
SDS-PAGE and Western blot analysis. Protein samples were analysed by SDS-PAGE on
gels containing 7.5% or 10% acrylamide. The gels were either stained with Coomassie brilliant
blue, or further used for Western blotting.
For Western blot analysis, proteins separated by SDS-PAGE were transferred to a nitrocel-
lulose membrane (Bio-Rad) and were blocked by overnight incubation with 10 mL blocking
buffer (20 mM Tris, 200 mM NaCl, 0.02% NaN3, pH 7.2) containing 1.5% casein. Proteins
were detected via their MBP fusion tag, by immunoblot analysis using a primary antibody (Rb
anti-Maltose Binding Protein polyclonal antibody, Abcam) at a dilution of 1:3500 and a sec-
ondary antibody (Ms anti-rabbit IgG (γ-chain specific)-peroxidase-conjugated monoclonal
antibody, Sigma) at a dilution of 1:10000 in blocking solution. The protein-antibody com-
plexes were detected utilizing a chemiluminescence system (Novex ECL HRP Chemilumines-
cent Substrate Reagent Kit, Invitrogen). The membranes were exposed for 3 seconds, and
images were evaluated using ImageJ software [26] to determine band density. Protein amounts
were calculated from density data with the aid of a calibration series of known amounts of
purified MBP.
In the case of ROCK2, alkaline phosphatase-conjugated secondary antibody (Gt anti-rabbit
IgG, Sigma) was also used at dilution of 1:3000 in blocking solution. After incubation, a
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mixture of nitro-blue tetrazolium (NBT) and 5-bromo-4-chloro-3’-indolyphosphate (BCIP)
was used for antibody complex detection.
Protein functional analysis
Kinase activities were determined using a Z’-LYTE Peptide Kinase Assay [27], with substrates
Ser/Thr peptide 1 for Aurora A and Ser/Thr peptide 13 for other kinases. Reaction buffer con-
tained 50 mM HEPES (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35, 1% DMSO,
20 μM ATP and 2 μM peptide substrate. The kinase reactions were incubated at 30˚C for 1
hour, followed by development by the included protease at 25˚C for 1 hour. Fluorescence
emissions were detected at 445 nm and 520 nm using an EnSpire Multimode Plate Reader.
Based on the emission values, and by using phosphorylation control solutions, phosphoryla-
tion amounts for each reaction were calculated using the formula provided in the Z’-Lyte man-
ual [28]. Phosphorylation percentage values were directly converted to concentrations.
Reactions with no more than 10% substrate consumption could be assumed to be in the linear
kinetics stage. Initial velocities were calculated from these data. We have obtained normalised
activity values by dividing these initial velocities by the concentration of the enzyme (expressed
in monomers).
Results and discussion
Vector design
Our modular, unified vector system, named pONE permits a one-step exchange of the gene of
interest among the vectors for recombinant protein expression in bacteria (E. coli), yeast (P.
pastoris), insect cell (S. frugiperda) and mammalian cells (HEK293 or CHO). This compatibil-
ity is ensured by an expression cassette with its multiple cloning site unified between all pONE
vectors (Fig 1). The multiple cloning site is not totally identical in all vectors, but for any pair
of vectors selected, there exists at least one compatible combination of restriction sites, which
might be used for direct cloning (Fig 2). The expression cassette (Fig 1) also has genes for MBP
(N-terminal) and His6 (C-terminal) fusion affinity tags, and an N-terminal secretion signal
may be included, too (before the MBP-tag).
MBP was chosen because it can be used directly in affinity purification schemes using rela-
tively inexpensive, common chromatographic media and it is widely regarded as a protein
folding chaperone that increases expression level of proteins fused to it (demonstrated in E.
coli and even in P. pastoris [29]).
The linker between the MBP and the target gene encodes the recognition site for either a
Tobacco Etch Virus protease (TEV [30, 31]) or a WELQut [32] protease, allowing the removal
of the large MBP tag from the protein product. The length and composition of the linker can
be fine-tuned by the careful selection of restriction sites for cloning. For example, the protease
cleavage site, a short hydrophobic streak or a Pro-Arg pair (providing some rigidity) can be
excluded or included depending on this choice. The expression cassette is modular in nature,
meaning that all auxiliary genes (affinity tags, secretion signal, and protease cleavage site) are
flanked by restriction sites, so they can be replaced or removed easily.
The pONE vector set contains bacterial, yeast, insect cell (baculoviral and transient) and
mammalian vectors, which are based on the commercially available pET-24d [20], pPIC9K
[23], pVL1393 [22], pIEx-1 [21] and pLEXm [1] vectors, respectively (Table 1 and Fig 2).
These vectors were selected because they are regarded as some of the best expression vectors
available. Most of these vectors were created in two variants: one including a secretion signal
specific for its host, and one without a secretion signal. The secretion variants have WELQut,
while the intracellular ones have TEV protease cleavage sites.
A unified and modular vector set for recombinant protein expression
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The protease choice was dictated by the buffers: TEV protease is a cysteine protease which
needs reducing environment for catalytic activity. The WELQut protease functions well in oxi-
dising environments too, because it is a serine protease, and therefore not redox-sensitive.
Intracellular cytosolic proteins often have free cysteines and require reducing conditions in
vitro to keep them active and prevent their aggregation. Secreted proteins are usually trans-
ferred into the extracellular space, and often have disulphide bonds required for their struc-
tural stability. The reducing TEV protease buffers present a risk for these disulphide bridges.
The non-reducing WELQut protease buffers are better suited for redox-sensitive proteins.
The bacterial vector uses the T7 promoter, enabling powerful induction of protein expres-
sion upon addition of IPTG. The Pichia expression systems traditionally utilize the AOX1 pro-
moter, which can be induced by the addition of methanol when no other carbon source is
present. We have also created a Pichia vector (pONE-25A), which has a constitutively active
GAP promoter. GAP promoter eliminates the need for using methanol and is less stressful for
the cells, which is an advantage in some situations, especially in large-scale applications. The
pIEX (pONE-32A and -33A) and pLEXm (-40A and -41A) based vectors can be used for tran-
sient transfection of insect and mammalian hosts, respectively, therefore they use constitutive
promoters too. For insect cells, baculovirus-based vectors (pONE-30A and -31A) were also
constructed.
Trial expressions with blank vectors
To test the functionality of pONE vectors, we have performed various trial expressions. In the
first series of experiments, “empty” vectors were tested to check whether the modifications did
affect their performance, and also to see if the protein is targeted properly in the presence or
absence of a secretion signal. Since all components of the expression cassette are in frame (Fig
1), the “empty” vectors yield fusion protein products, with MBP as their major part. These
experiments were performed with all vectors, excluding pONE-25A, which was tested by
expressing ROCK2 kinase (cf. next chapter). After expression, total protein content of the cells
and expression media were analysed–the recombinant product was detected via Western blot
using an MBP-specific antibody. The resulting blot images, with three parallel experiments for
each pONE construct are presented in Fig 3. From these data the relative distribution of MBP
between the medium and cytoplasm was calculated for each vector and are summarized in
Table 2.
These experiments prove that all pONE vectors are functional–significant quantities of
MBP were produced by each expression system (Fig 3). In general, it is in line with those
observations, that found MBP is a useful and expression enhancing tag even in higher eukary-
otes [33–36]. The variations between parallel experiments are relatively small, indicating
reproducibility of expression. Protein targeting works very well–although in the case of the
pONE-31A (and probably -41A) secretion vectors pronounced intracellular protein retention
could be detected. This could be explained by aggregation of the overexpressed protein, which
reduces secretion efficiency. For pONE-31A another possible cause might be the blockage of
the endoplasmic reticulum by baculoviral proteins.
Expression of a complex protein kinase, ROCK2
In the next phase of the project, we applied the pONE vectors to a real-life problem. To study
the activation mechanism of ROCK2, a large size (molecular mass of 164 kDa) multidomain,
multifunctional kinase, associated with neurodegenerative diseases [9, 37], by in vitro ex-
periments we aimed to develop a reproducible protocol for its expression and purification.
Therefore, to determine which provides the most functional protein, we have performed a
A unified and modular vector set for recombinant protein expression
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systematic expression screen of ROCK2 in expression hosts E. coli, P. pastoris and the baculo-
virus-insect cell system. As ROCK2 has successfully been produced in insect cells in the past
[10], we expected this host to be the most suitable one.
A variant of the ROCK2 gene, optimized for expression in insect cells, was synthesized for
the expression screening. This gene was ligated into the intracellular vectors pONE-10K (E.
coli), pONE-25A (P. pastoris) and pONE-30A (S. frugiperda). After expression, recombinant
ROCK2 was purified from the cell lysates using amylose affinity chromatography. Samples
were taken after both protein expression and purification for analysis by SDS-PAGE and
Western blotting (Fig 4). Protein yields, normalized to wet cellular mass are presented in
Table 3 –all data represent three parallel experiments. As a functional test of the recombinant
proteins their enzymatic activities were also measured as described in Methods.
Expression in insect cells (S. frugiperda) was robust (Fig 4), with negligible protein degrada-
tion (relative amounts are shown better by Coomassie staining than by Western blotting). In
contrast, we have found that E. coli is ill-suited for ROCK2 expression, even when using the
codon supplemented Rosetta2 strain. Most of the product is degraded or expressed truncated–
the amount of full-length ROCK2 is minuscule. For expression in yeast cells (P. pastoris) we
have utilized a protease-deficient strain SMD1168. Here ROCK2 was expressed under the
Fig 3. Expression patterns of MBP using pONE vectors demonstrate that proteins of interest are expressed and
directed to the relevant compartment. Recombinant MBP (~45 kDa) was expressed in various hosts and pONE
vectors, as described in Materials and Methods. Three parallel experiments were performed for each vector (marked by
numbers 1–3). Samples were taken from the expression media (‘Extracellular’) and cell lysates (‘Intracellular’), then
analysed via SDS PAGE followed by Western blotting. Relative dilutions (each valid within a given blot) are marked
below the corresponding lanes. An anti-MBP antibody was used for detection of the recombinant protein. Blots were
developed in a bioluminescent reaction (cf. Materials and Methods). Band intensities were determined by
densitometry, and converted to total protein mass using internal calibration standards on each blot, with known
amounts of MBP. Distribution of MBP between the extra- and intracellular compartments is presented in Table 2. (A)
pONE-10K is a vector for intracellular protein expression in E. coli. Considering the sample dilutions, protein leakage
is negligible. An MBP form of smaller molecular mass is also present, especially in the extracellular samples. This is
likely the form natively expressed by E. coli, which has a molar weight of ~43 kDa (our recombinant variant is ~45
kDa). (B) MBP expression in P. pastoris using the pONE-23A (intracellular) and pONE-24A (secretion) vectors. Some
inhomogeneities are detectable in the intracellular samples. These are most probably degradation products, resulting
from protease activity in the cytoplasm. (C) pONE-30A (intracellular) and pONE-31A (secretion) are baculovirus
based vectors for S. frugiperda cells, while pONE-32A (intracellular) and pONE-33A (secretion) are used for transient
transfection. No degradation is observed. MBP targeting works well, with the probable exception of pONE-31A, where
approximately half of the product is held back in the cell. (D) MBP expression in HEK293 cells, using the pLEXm
based pONE-40A (intracellular) and pONE-41A (secretion) vectors. Intracellular retention of some MBP with the
pONE-41A vector can be observed, this is probably misfolded material.
https://doi.org/10.1371/journal.pone.0227110.g003
Table 2. Expression yields and localization of recombinant MBP in various hosts. Western blots (Fig 3) were subjected to densitometric analysis using ImageJ software
[26]. Results were quantified using calibration standards on each Western blot. From these data relative distributions of MBP between the extracellular and intracellular
compartments were calculated. “nd” means “not detected”. Expression patterns of MBP using pONE vectors demonstrate that proteins of interest are expressed and
directed to the relevant compartment.
Host Vector Distribution of MBP between compartments
Extracellular Intracellular
Bacteria pONE-10K <1% >99%
Yeast pONE-23A nd 100%
pONE-24A 100% nd
Insect pONE-30A 8 ±1% 92 ±1%
pONE-31A 49 ±10% 51 ±10%
pONE-32A nd 100%
pONE-33A 96 ± 1% 4 ±1%
Mammal pONE-40A nd 100%
pONE-41A 82 ±3% 18 ±3%
https://doi.org/10.1371/journal.pone.0227110.t002
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Fig 4. ROCK2 expression and purification in various hosts. To test the pONE vector set we have used it for the expression screening of a large, multi-domain
human protein, the ROCK2 kinase. ROCK2 was expressed in the bacterium E. coli, the yeast P. pastoris and the insect cell S. frugiperda using the intracellular vectors
pONE-10K, pONE25-A and pONE30-A, respectively. Cells were lysed and ROCK2 purified from the lysate by amylose affinity chromatography. Samples were taken
during the process, and analysed by SDS PAGE and Western blotting using anti-MBP antibody (upper and lower images, respectively). As for the evaluation of the
results, it is notable that impurities are generally more visible on Western blots due to its greater sensitivity and non-linearity compared to Coomassie staining. Each
image presents the total protein content after expression (‘Total’) and the purified protein after the affinity chromatography (‘Purified’). Bands corresponding to full-
length ROCK2 (‘FL’, Mw ~206 kDa with the fusion MBP tag) and the main degradation product (‘DEG’) are marked. E. coli is not suitable for ROCK2 expression, as
the amount of full-length protein expressed is negligible compared to the degradation products, likely due to folding problems. In this host, the ROCK2 segment (Mw
~161 kDa) of the fusion protein degrades almost completely, while MBP (Mw ~45 kDa) remains intact, probably protected by its correct fold. In eukaryotic hosts,
however, the bulk of ROCK2 is expressed as its full-length form. ROCK2 expressed in P. pastoris proved to be at least as pure as that expressed in S. frugiperda, the
most commonly used host for ROCK2 expression. In fact, the presence of degradation products appears to be lower than in insect cells. However, both in P. pastoris
and S. frugiperda a small amount of impurities appear along with the purified protein. Based on the Western blots, these are host proteins in the case of P. pastoris, and
degradation products of ROCK2 in the case of S. frugiperda. In insect cells the degradation product is probably a fragmented MBP-ROCK2 fusion protein, where the
C-terminal domain(s) of ROCK2 are cleaved off. It is demonstrated that yeast can effectively substitute insect cell culture for the expression of large, complex, multi-
domain proteins.
https://doi.org/10.1371/journal.pone.0227110.g004
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GAP promoter. The product was at least as homogenous as that expressed by the baculovirus-
insect cell system.
For functional comparison of the ROCK2 products expressed in different hosts we have
performed enzyme activity measurements using a Z’-Lyte assay kit (cf. Materials and meth-
ods). We cannot be sure if the substrate concentrations used in these experiments (especially
the peptide at 2 μM) are at saturation. Because the conditions were identical in all reactions,
the resulting activities are suitable for comparison between ROCK2 forms expressed in various
hosts. Activities obtained were 0.03 ±0.01, 1.44 ±0.73, 1.05 ±0.38 [mole product] / ([mole
enzyme] � min) for E. coli, S. frugiperda and P. pastoris, in the same order. These data also sup-
port that E. coli is unfit for ROCK2 expression: this product proved practically inactive. Insect
cell- and yeast-produced ROCK2 functioned much better, with comparable activities.
Our experiments demonstrate that ROCK2 purified from yeast cells is functionally equiva-
lent to the protein expressed in insect cells. Expression in the insect cells (S. frugiperda) still
yields more ROCK2 per unit of cellular mass compared to yeast (P. pastoris). However, consid-
ering that protein expression in yeast is cheaper and much more scalable than in insect cells, P.
pastoris could be, in many cases, a better and more economical choice for ROCK2 production,
especially if mutagenesis studies are to be performed.
Further examples for application of the pONE vector set
We have also successfully applied the pONE vector set to the expression of a number of other pro-
teins. Namely, the tumour-suppressor RASSF1A, its oncogenic protein kinase, Aurora A [38]and
another protein kinase, LIMK1. For these proteins, we do not show the expression trials, only the
results of their expression and purification using the finally selected vectors (Fig 5, Table 3). Other
examples for successful application of pONE vectors are described elsewhere: the expression of
immunomodulators galectin-13 and -14 [39] and variants of UDP-glycosyltransferase [40]. The
two galectins, the glycosyltransferase, the kinase domain of Aurora A and a deletion mutant of
RASSF1A (with residues 121–340) could be obtained in a pure and functional form by expression
in E. coli using the vector pONE-10K. LIMK1 was expressed in insect cells using the baculovirus
based vector, pONE-30A. This enzyme could also be purified in an active, functional form.
Comparison between the pONE vector set and existing expression systems
Expression vectors of different origins are rarely developed with compatibility in mind. This
complicates the expression screening process often necessary when working with novel
Table 3. Yields and activities for proteins expressed using pONE vectors. Purification yields and functionality of full-length human ROCK2, Aurora A and LIMK1
kinases as well as a RASSF1A fragment expressed by different hosts (as illustrated by Figs 4 and 5).
Protein Host Vector Purified protein / 1g wet cell mass Enzyme activity
ROCK2 E. coli
(bacterium)
pONE-10K 1.2 ± 0.2 μg -
P. pastoris
(yeast)
pONE-25A 21 ± 2 μg +
S. frugiperda (insect cells) pONE-30A 300 ± 30 μg +
RASSF1A fragment E. coli pONE-10K 235 ± 78 μg �
Aurora A kinase domain E. coli pONE-10K 137 ± 45 μg +
LIMK1 S. frugiperda pONE-30A 750 ± 230 μg +
+/- signs mark if the enzyme was found active.
� marks that RASSF1A inherently lacks enzyme activity.
https://doi.org/10.1371/journal.pone.0227110.t003
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proteins. There are multiple vector systems designed to facilitate expression screening of vari-
ous hosts, promoters or fusion tags. Some examples are the pBV boost [41], pDEP [42], pAUL
[4] or pCri [5] systems. However, most systems are suitable only for a limited set of hosts, do
not include variable auxiliary elements (expression tags, signal peptides), utilize complicated
cloning techniques, or were developed for a specific task making them ill-suited for general
research purposes.
The pONE system includes vectors for the four most widely used expression hosts: the bac-
terial, yeast, insect and mammalian systems. These vectors share a unified expression cassette,
which allows rapid transfer of genes of interest between them. Cloning is achieved by the com-
mon restriction digestion/ligation method, which does not require expensive reagents or spe-
cial knowledge, and is readily available at most research laboratories. The expression cassette
also includes genes for MBP- and His6- fusion tags and in some vectors a secretion signal too.
These are flanked by restriction sites and so can easily be removed or replaced by other
sequences. The linker between MBP and the protein of interest includes a protease cleavage
site, so MBP can be removed from the product easily. Also, the length and composition of the
linker can be fine-tuned by selecting the appropriate restriction site for cloning. To sum up,
the pONE vector set is a useful tool for general expression screening in a wide variety of host
organisms, affinity tags and protein targeting, most suitable for small-scale research use.
Conclusion
We have developed a new set of expression vectors, named the pONE series, suitable for pro-
tein expression in various, common host organisms. These vectors carry a unified, modular
Fig 5. Purity of various protein constructs expressed using pONE vectors. The pONE vector set was also applied to
express the following proteins. Full-length LIMK1 (Mw ~117 kDa) was expressed in the insect cells S. frugiperda, using
the vector pONE-30A. The kinase domain of Aurora kinase A (Mw ~79 kDa) as well as a RASSF1A fragment (residues
121–340, Mw ~70 kDa) were both expressed in the bacterium E. coli using pONE-10K. All molecular masses
correspond to the recombinant proteins in fusion with an MBP tag. Samples were taken before harvesting the cells
(‘Total’) and from the final, purified protein product (‘Purified’). The samples were analysed by SDS-PAGE and
subsequent staining by Coomassie brilliant blue. All proteins were expressed in substantial quantities (Table 3), and
could be purified. Using pONE vectors, pure recombinant proteins (LIMK1, Aurora A kinase domain and a RASSF1A
fragment) were obtained with high yield.
https://doi.org/10.1371/journal.pone.0227110.g005
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expression cassette, which allows rapid expression screening of novel proteins, and easy
manipulation of fusion tags and signal peptides. Trial expressions of MBP protein carried by
the “empty” vectors proves the functionality of all members of the vector set, including the
proper targeting of recombinant proteins by an optional secretion signal. We have also dem-
onstrated the usefulness of pONE vectors by applying them to the expression and purification
of various complex proteins, namely ROCK2, LIMK1 and Aurora A kinases, the tumour sup-
pressor RASSF1A and immunomodulators galectin-13 and -14. A significant finding of practi-
cal importance arose from the expression screening of ROCK2. Expression of this large, multi-
domain protein in P. pastoris yielded a product with equal activity to that expressed in insect
cell culture, which is commonly used for production of ROCK2. Since yeast-based expression
systems are far more scalable than insect cell cultures, we expect that these results provide a
promising alternative instead of the error-prone and costly insect cell expression.
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